With so much BRCA doom and gloom, there is research to brighten the horizon. Organizations like HeritX are determined to prevent inherited cancer. Since the writing of this post, HeritX, changed their name to Cancer Prevention Initiative (CPI)
Luckily, CPI is working diligently to come up with a solution to the BRCA mutation sooner than later, in the form of a possible vaccine to protect against breast cancer. They do this by offering grants for research projects directed toward any given preventative therapies. For instance, can the mutated BRCA1 or BRCA2 gene be fixed or stabilized? Cancer research funding has been mainly directed toward treatment, and CPI feels as though the pendulum needs to shift.
BRCA genetic mutation positive people may eventually feel as though they have other viable options besides super invasive surgeries. Most importantly, CPI offers hope for our future, as well as opens options for our children who may be affected.
I first came across HeritX, now CPI at my first BRCA conference. I became intrigued by their determination. Current Research and Development practices, otherwise known as R&D, can take up to 15 years to make a therapy available to the general public. However, with CPI Accelerated R&D, they believe they can accomplish it in less than 10 years.
CPI is not just worrying about BRCA-related cancers, they are working on preventing them. The founders are either closely connected with a BRCA positive person or a mutation carrier themselves; thus, they are fully invested.
Do you know someone who is focusing their research on preventing inherited cancer? If so, send them to CPI for sure!
Our words have power, but our actions shape our lives. ~Rachel Hollis